Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Technology Advances in Modular and Automated Platforms for Pharmaceutical Manufacturing

Increasing demand for small molecule drugs is driving the growth of modular and automated technologies in pharmaceutical manufacturing

RELEASE DATE
10-Sep-2024
REGION
Global
Deliverable Type
Technology Research
Research Code: DB03-01-00-00-00
SKU: HC_2024_1004
AvailableYesPDF Download
$4,950.00
In stock
SKU
HC_2024_1004
$4,950.00
DownloadLink
Purchase includes:
  • Report download
  • Growth dialog™ with our experts
Need more details?

Description

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized medicine sector. Advancements in technology are also influenced by the pharma 4.0 trend, which entails higher usage of artificial intelligence (AI), the Internet of Things (IoT), and big data analytics. These developments help improve efficiency and productivity, identify errors in manufacturing at an early stage, and maintain audit trails through digitization. They have reduced human intervention, brought flexibility, and made cleanups and changeovers easier. Some of these technologies are already seeing widespread use, while others, such as robotics, are expected to witness a gradual increase in adoption. The effects of modular and automated technologies in manufacturing will be revolutionary in terms of production speeds, error reduction, precision, and cost savings.

The study considers each step in the manufacturing process to analyze the unmet needs and developments in this space. It focuses on widely adopted as well as emerging solutions, listing the key companies offering these advanced technologies. It also provides an overview of the funding and investment landscape and looks at the key partnerships influencing the market. The study analyzes the factors driving and restraining the growth of this industry and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2023, and the forecast period is from 2024 to 2027.

Table of Contents

Why Is It Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top 3 Strategic Imperatives on Modular and Automated Platforms for Pharmaceutical Manufacturing

Growth Opportunities Fuel the Growth Pipeline Engine™

Research Methodology

Scope of Analysis

Segmentation

Growth Drivers

Growth Restraints

Steps in the Large-scale Pharma Manufacturing of Small-molecule Drugs

Challenges in Small-molecule Drug Production

Qualities Needed in Blending Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Modular Blending Technologies

Snapshot of Companies with Modular Blending Technologies (continued)

Qualities Needed in Granulation Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Modular Granulation Technologies

Qualities Needed in Tablet Compression/Capsule Filling Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Modular Tablet Compression/Capsule Filling Technologies

Qualities Needed in Tablet Coating Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Tablet Coating Technologies

Qualities Needed in Packing Technologies for Pharmaceutical Manufacturing

Snapshot of Companies with Packing Technologies

Modular and Automated Manufacturing Techniques Driven by Pharma 4.0

Modular Manufacturing Technology Use Cases

Modular and Automated Manufacturing Technologies for Sustainable and Personalized Medicines

Present and Future of Modular Technology Adoption in Small-molecule Therapeutics Manufacturing

Industrial Trends due to Modular and Automated Pharmaceutical Manufacturing

Partnerships Promoting Innovative Manufacturing Processes

Fundings and Grants from Private and Public Sources for Manufacturing Technologies

Growth Opportunity 1: Personalized Medicines

Growth Opportunity 1: Personalized Medicines (continued)

Growth Opportunity 2: Sustainability

Growth Opportunity 2: Sustainability

Growth Opportunity 3: Robotics

Growth Opportunity 3: Robotics

Benefits and Impacts of Growth Opportunities

Next Steps

Legal Disclaimer

Growth dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This study examines technology advances in modular and automated platforms for non-biologics manufacturing in the pharmaceutical sector. There is a growing demand for automated and modular technologies that ensure regulatory compliance, increase productivity, reduce waste, and meet emerging therapeutic requirements such as those of the personalized medicine sector. Advancements in technology are also influenced by the pharma 4.0 trend, which entails higher usage of artificial intelligence (AI), the Internet of Things (IoT), and big data analytics. These developments help improve efficiency and productivity, identify errors in manufacturing at an early stage, and maintain audit trails through digitization. They have reduced human intervention, brought flexibility, and made cleanups and changeovers easier. Some of these technologies are already seeing widespread use, while others, such as robotics, are expected to witness a gradual increase in adoption. The effects of modular and automated technologies in manufacturing will be revolutionary in terms of production speeds, error reduction, precision, and cost savings. The study considers each step in the manufacturing process to analyze the unmet needs and developments in this space. It focuses on widely adopted as well as emerging solutions, listing the key companies offering these advanced technologies. It also provides an overview of the funding and investment landscape and looks at the key partnerships influencing the market. The study analyzes the factors driving and restraining the growth of this industry and identifies the opportunities emerging from the changes in this space for market players and stakeholders to leverage. The base year is 2023, and the forecast period is from 2024 to 2027.
More Information
Deliverable Type Technology Research
Author Lonita lawrence
Industries Healthcare
No Index No
Is Prebook No
Podcast No
WIP Number DB03-01-00-00-00